These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 10505759)

  • 1. Stable transfection of a glypican-1 antisense construct decreases tumorigenicity in PANC-1 pancreatic carcinoma cells.
    Kleeff J; Wildi S; Kumbasar A; Friess H; Lander AD; Korc M
    Pancreas; 1999 Oct; 19(3):281-8. PubMed ID: 10505759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The cell-surface heparan sulfate proteoglycan glypican-1 regulates growth factor action in pancreatic carcinoma cells and is overexpressed in human pancreatic cancer.
    Kleeff J; Ishiwata T; Kumbasar A; Friess H; Büchler MW; Lander AD; Korc M
    J Clin Invest; 1998 Nov; 102(9):1662-73. PubMed ID: 9802880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glypican-1 is overexpressed in human breast cancer and modulates the mitogenic effects of multiple heparin-binding growth factors in breast cancer cells.
    Matsuda K; Maruyama H; Guo F; Kleeff J; Itakura J; Matsumoto Y; Lander AD; Korc M
    Cancer Res; 2001 Jul; 61(14):5562-9. PubMed ID: 11454708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glypican-1 antisense transfection modulates TGF-beta-dependent signaling in Colo-357 pancreatic cancer cells.
    Li J; Kleeff J; Kayed H; Felix K; Penzel R; Büchler MW; Korc M; Friess H
    Biochem Biophys Res Commun; 2004 Aug; 320(4):1148-55. PubMed ID: 15249209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo and in vitro degradation of heparan sulfate (HS) proteoglycans by HPR1 in pancreatic adenocarcinomas. Loss of cell surface HS suppresses fibroblast growth factor 2-mediated cell signaling and proliferation.
    Xu X; Rao G; Quiros RM; Kim AW; Miao HQ; Brunn GJ; Platt JL; Gattuso P; Prinz RA
    J Biol Chem; 2007 Jan; 282(4):2363-73. PubMed ID: 17121850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of autocrine and paracrine functions of basic fibroblast growth factor by stable expression of perlecan antisense cDNA.
    Aviezer D; Iozzo RV; Noonan DM; Yayon A
    Mol Cell Biol; 1997 Apr; 17(4):1938-46. PubMed ID: 9121441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nerve growth factor and enhancement of proliferation, invasion, and tumorigenicity of pancreatic cancer cells.
    Zhu Z; Kleeff J; Kayed H; Wang L; Korc M; Büchler MW; Friess H
    Mol Carcinog; 2002 Nov; 35(3):138-47. PubMed ID: 12410565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of basal and mitogen-stimulated pancreatic cancer cell growth by cyclin D1 antisense is associated with loss of tumorigenicity and potentiation of cytotoxicity to cisplatinum.
    Kornmann M; Arber N; Korc M
    J Clin Invest; 1998 Jan; 101(2):344-52. PubMed ID: 9435306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glypican-4 is an FGF2-binding heparan sulfate proteoglycan expressed in neural precursor cells.
    Hagihara K; Watanabe K; Chun J; Yamaguchi Y
    Dev Dyn; 2000 Nov; 219(3):353-67. PubMed ID: 11066092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pancreatic cancer cell-derived vascular endothelial growth factor is biologically active in vitro and enhances tumorigenicity in vivo.
    Luo J; Guo P; Matsuda K; Truong N; Lee A; Chun C; Cheng SY; Korc M
    Int J Cancer; 2001 May; 92(3):361-9. PubMed ID: 11291072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glypican-3, overexpressed in hepatocellular carcinoma, modulates FGF2 and BMP-7 signaling.
    Midorikawa Y; Ishikawa S; Iwanari H; Imamura T; Sakamoto H; Miyazono K; Kodama T; Makuuchi M; Aburatani H
    Int J Cancer; 2003 Feb; 103(4):455-65. PubMed ID: 12478660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phenotypic alterations in Kaposi's sarcoma cells by antisense reduction of perlecan.
    Marchisone C; Del Grosso F; Masiello L; Prat M; Santi L; Noonan DM
    Pathol Oncol Res; 2000; 6(1):10-7. PubMed ID: 10749582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation of glypican-1 expression with TGF-beta, BMP, and activin receptors in pancreatic ductal adenocarcinoma.
    Kayed H; Kleeff J; Keleg S; Jiang X; Penzel R; Giese T; Zentgraf H; Büchler MW; Korc M; Friess H
    Int J Oncol; 2006 Nov; 29(5):1139-48. PubMed ID: 17016645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transforming growth factor beta 1 (TGF beta 1) is an autocrine positive regulator of colon carcinoma U9 cells in vivo as shown by transfection of a TGF beta 1 antisense expression plasmid.
    Huang F; Newman E; Theodorescu D; Kerbel RS; Friedman E
    Cell Growth Differ; 1995 Dec; 6(12):1635-42. PubMed ID: 9019169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heparan sulfate proteoglycans as regulators of fibroblast growth factor-2 signaling in brain endothelial cells. Specific role for glypican-1 in glioma angiogenesis.
    Qiao D; Meyer K; Mundhenke C; Drew SA; Friedl A
    J Biol Chem; 2003 May; 278(18):16045-53. PubMed ID: 12591930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TIMP-1 antisense gene transfection attenuates the invasive potential of pancreatic cancer cells in vitro and inhibits tumor growth in vivo.
    Bloomston M; Shafii A; Zervos E; Rosemurgy AS
    Am J Surg; 2005 Jun; 189(6):675-9. PubMed ID: 15910719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth factor-induced shedding of syndecan-1 confers glypican-1 dependence on mitogenic responses of cancer cells.
    Ding K; Lopez-Burks M; Sánchez-Duran JA; Korc M; Lander AD
    J Cell Biol; 2005 Nov; 171(4):729-38. PubMed ID: 16286510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amplification of AKT2 in human pancreatic cells and inhibition of AKT2 expression and tumorigenicity by antisense RNA.
    Cheng JQ; Ruggeri B; Klein WM; Sonoda G; Altomare DA; Watson DK; Testa JR
    Proc Natl Acad Sci U S A; 1996 Apr; 93(8):3636-41. PubMed ID: 8622988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of glypican-1 on turkey skeletal muscle cell proliferation, differentiation and fibroblast growth factor 2 responsiveness.
    Velleman SG; Liu C; Coy CS; McFarland DC
    Dev Growth Differ; 2006 May; 48(4):271-6. PubMed ID: 16681652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hsulf-1 regulates growth and invasion of pancreatic cancer cells.
    Abiatari I; Kleeff J; Li J; Felix K; Büchler MW; Friess H
    J Clin Pathol; 2006 Oct; 59(10):1052-8. PubMed ID: 16603650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.